Can Bradykinin Be a Target for Toxicity Treatment?
Yes, targeting bradykinin pathways can be a strategy for mitigating toxicity. The development of bradykinin receptor antagonists has provided therapeutic options to counteract the harmful effects of excessive bradykinin. These antagonists can help reduce inflammation and vascular permeability, thereby minimizing tissue damage in various toxicological scenarios.
